Advertisement
*
Reproduction permitted for personal use only. For reprints and reprint permission, contact reprints@wistechnology.com.
Digest

Perscitus Biosciences secures $250K Commerce loan

Madison, Wis. - Perscitus Biosciences, a Madison biotechnology company, has received a $250,000 loan from the Wisconsin Department of Commerce.

Perscitus Biosciences was founded in 2006 to develop and commercialize two technologies based on reactive oxygen biochemistry. James Thomas, CEO and chairman of Perscitus Biosciences, said the Commerce loan will be used to purchase equipment and hire researchers to further develop its technologies and attract additional investment.

The first technology is a compound that selectively protects normal cells from the toxic effects of chemotherapy and radiation therapy. The second technology is a method for determining the function of unknown proteins by identifying protein binding partners in intact cells using reactive oxygen.

Thomas said the company has rapidly achieved its early proof-of-concept milestones.

Related stories
Advertisement
Madison stem cell company gets $1M from state

Doyle announces technology tax credits for Berbee

State to fund two minority-owned tech businesses

-Add Your Comment

Name:
E-mail:

Comment Policy: WTN News accepts comments that are on-topic and do not contain advertisements, profanity or personal attacks. Comments represent the views of the individuals who post them and do not necessarily represent the views of WTN Media or our partners, advertisers, or sources. Comments are moderated and are not immediately posted. Your email address will not be posted.

WTN Media cannot accept liability for the content of comments posted here or verify their accuracy. If you believe this comment section is being abused, contact edit@wistechnology.com.

WTN Media Presents